Company performance
Add to research
Current Price
as of Mar 14, 2025$67.86
P/E Ratio
438.09
Market Cap
$13.13B
Description
Add to research
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.
Metrics
Add to research
Overview
- HQWilmington, DE
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerINCY
- Price$67.86+0.22%
Trading Information
- Market cap$13.13B
- Float98.55%
- Average Daily Volume (1m)1,550,065
- Average Daily Volume (3m)1,666,024
- EPS$0.16
Company
- Revenue$4.24B
- Rev growth (1yr)14.76%
- Net income$32.62M
- Gross margin91.09%
- EBITDA margin3.99%
- EBITDA$169.39M
- EV$12.44B
- EV/Revenue2.93
- P/E438.09
- P/S3.37
- P/B3.81
- Debt/Equity1.75
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account